Caprospinol, Therapy for Alzheimer's Disease (AD)
Key Data:
Drug (Brand/Generic)
Caprospinol (SP-233)
Company/Licensee
Samaritan Pharmaceuticals
Therapy Class
Spirostenol
Product Description
Anti-amyloid agent
Current Indication
Alzheimer's disease
Market Sector
CNS
Development Status
Preclinical – IND number received from the US FDA. Phase I clinical studies yet to be started.
